The Use of Alteplase for Restoring Patency to Occluded Central Venous Access Devices in Infants and Children

Journal of Infusion Nursing

Volumn 27, Issue 3, 2004, Pages 171-174

  Fisher, Amy A ^a   Deffenbaugh, Claudia ^a   Poole, Robert L ^a   Garcia, Manuel ^a,b   Kerner Jr , John A ^a,b  

^a LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRIN; FIBRINOLYTIC AGENT; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ALLERGIC REACTION; ARTICLE; CATHETER INFECTION; CENTRAL VEIN; CENTRAL VENOUS CATHETER; CHILD; DEVICE; DRUG EFFICACY; DRUG SAFETY; FIBRINOLYSIS; HUMAN; INFANT; PLASMA HALF LIFE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VASCULAR ACCESS; VASCULAR PATENCY; VEIN OCCLUSION;

ADOLESCENT; ADULT; CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; MALE; PEDIATRIC NURSING; RETROSPECTIVE STUDIES; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR PATENCY;

EID: 2342458433     PISSN: 15331458     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129804-200405000-00006     Document Type: Article

References (7)

1. Haire WD, Herbst SL. Use of alteplase (t-PA) for the management of thrombotic catheter dysfunction: guidelines from a consensus conference of the National Association of Vascular Access Networks (NAVAN). Nutr Clin Pract. 2000;15:265-275.
2. Chesler L, Feusner JH. Use of tissue plasminogen activator (rt-PA) in young children with cancer and dysfunctional central venous catheters. J Pediatr Hematol Oncol. 2002;24(8):653-656.
3. Choi M, Massicotte MP, Marizinotto V, et al. The use of alteplase to restore patency of central venous lines in pediatric patients: a cohort study. J Pediatr. 2001;139(1):152-156.
4. Jacobs BR, Haygood M, Hingl J. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children. J Pediatr. 2001;139(4):593-595.
5. Shen V, Murdock M, Resnansdy L, et al. Recombinant tissue plasminogen activator (Alteplase) for restoration of function to occluded central venous catheters in pediatric patients. J Pediatr Hematol Oncol. 2003;25(1):38-45.
6. Fisher AA, Deffenbaugh CA, Poole RL, et al. Recombinant tissue plasminogen activator (Alteplase) for restoring patency to occluded central venous access devices in infants and children. Presented as a poster at the Infusion Nurses Society Annual Meeting; May 2002; Phoenix, Arizona.
7. Gorski LA. Central venous access device occlusions: Part 1. Thrombotic causes and treatment. Home Healthcare Nurse. 2003;21(2):115-122.